305 related articles for article (PubMed ID: 23329897)
21. Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.
Sims KA; Woodland AM
Pharmacotherapy; 2006 Dec; 26(12):1745-57. PubMed ID: 17125436
[TBL] [Abstract][Full Text] [Related]
22. Chronic heart failure. A guide for practical management.
O'Driscoll G
Aust Fam Physician; 2000 May; 29(5):423-7. PubMed ID: 10835779
[TBL] [Abstract][Full Text] [Related]
23. Nonresponse to treatment for hepatitis C: current management strategies.
Yuan HJ; Lee WM
Drugs; 2008; 68(1):27-42. PubMed ID: 18081371
[TBL] [Abstract][Full Text] [Related]
24. New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage.
Yin GQ; Li J; Zhong B; Yang YF; Wang MR
World J Gastroenterol; 2021 Feb; 27(8):666-676. PubMed ID: 33716446
[TBL] [Abstract][Full Text] [Related]
25. Mechanical bridge to decision: what are the options for the management of acute refractory cardiogenic shock?
Goldstein D; Neragi-Miandoab S
Curr Heart Fail Rep; 2011 Mar; 8(1):51-8. PubMed ID: 21161450
[TBL] [Abstract][Full Text] [Related]
26. Management of hepatitis C/HIV coinfection.
Rockstroh JK
Curr Opin Infect Dis; 2006 Feb; 19(1):8-13. PubMed ID: 16374211
[TBL] [Abstract][Full Text] [Related]
27. [Renal replacement therapy for refractory heart failure].
Schwenger V; Remppis AB
Internist (Berl); 2012 Jul; 53(7):823-32. PubMed ID: 22674449
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic aspects of hepatitis C in hemodialysis patients.
Hosseini Moghaddam SM; Alavian SM; Rahnavardi M
Am J Nephrol; 2009; 29(2):123-8. PubMed ID: 18719345
[TBL] [Abstract][Full Text] [Related]
29. Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.
Perry CM
Drugs; 2012 Mar; 72(5):619-41. PubMed ID: 22439668
[TBL] [Abstract][Full Text] [Related]
30. Screening, diagnosis, treatment, and management of hepatitis C: a novel, comprehensive, online resource center for primary care providers and specialists.
Lebovics E; Czobor K
Am J Med; 2014 Nov; 127(11):e11-e14. PubMed ID: 25308624
[TBL] [Abstract][Full Text] [Related]
31. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis.
Hanouneh M; Ritchie MM; Ascha M; Ascha MS; Chedid A; Sanguankeo A; Zein NN; Hanouneh IA
Scand J Gastroenterol; 2019 Jan; 54(1):76-80. PubMed ID: 30650311
[TBL] [Abstract][Full Text] [Related]
32. Current status and future directions in the management of chronic hepatitis C.
Aman W; Mousa S; Shiha G; Mousa SA
Virol J; 2012 Mar; 9():57. PubMed ID: 22385500
[TBL] [Abstract][Full Text] [Related]
33. Viral hepatitis in patients on hemodialysis.
Winston A; Wurcel AG; Gordon C; Goyal N
Semin Dial; 2020 May; 33(3):254-262. PubMed ID: 32394502
[TBL] [Abstract][Full Text] [Related]
34. Update on viral hepatitis in 2004.
Fung SK; Lok AS
Curr Opin Gastroenterol; 2005 May; 21(3):300-7. PubMed ID: 15818150
[TBL] [Abstract][Full Text] [Related]
35. Management of Difficult Cases of Autoimmune Hepatitis.
Lammert C; Loy VM; Oshima K; Gawrieh S
Curr Gastroenterol Rep; 2016 Feb; 18(2):9. PubMed ID: 26780632
[TBL] [Abstract][Full Text] [Related]
36. CD8+ T-Cell Responses in Hepatitis B and C: The (HLA-) A, B, and C of Hepatitis B and C.
Nitschke K; Luxenburger H; Kiraithe MM; Thimme R; Neumann-Haefelin C
Dig Dis; 2016; 34(4):396-409. PubMed ID: 27170395
[TBL] [Abstract][Full Text] [Related]
37. Practical management of chronic hepatitis B infection.
Tsai NC
Semin Liver Dis; 2004; 24 Suppl 1():71-6. PubMed ID: 15192804
[TBL] [Abstract][Full Text] [Related]
38. Prevention and management of treatment failure to new oral hepatitis C drugs.
Benítez-Gutiérrez L; Barreiro P; Labarga P; de Mendoza C; Fernandez-Montero JV; Arias A; Peña JM; Soriano V
Expert Opin Pharmacother; 2016 Jun; 17(9):1215-23. PubMed ID: 27149603
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment.
Masip M; Tuneu L; Pagès N; Torras X; Gallego A; Guardiola JM; Faus MJ; Mangues MA
Int J Clin Pharm; 2015 Dec; 37(6):1143-51. PubMed ID: 26267215
[TBL] [Abstract][Full Text] [Related]
40. Sustained viral response to pegylated interferon alpha-2b and ribavirin in chronic hepatitis C refractory to prior treatment.
Mathew A; Peiffer LP; Rhoades K; McGarrity T
Dig Dis Sci; 2006 Nov; 51(11):1956-61. PubMed ID: 17004124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
